TickerFacts.

Phathom Pharmaceuticals, Inc. (PHAT): Gross Profit

Annual figures by period end, from SEC filings.

$152.51M
Year ended 2025-12-31
$198.73M
Trailing 12 months to 2026-06-30
2022-12-31: $02023-12-31: $515.0K2024-12-31: $47.28M2025-12-31: $152.51M$152.51M
2022-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$152.51M+222.6%2026-02-26, From 2025-01-01
2024-12-31$47.28Mn/m2026-02-26, From 2024-01-01
2023-12-31$515.0Kn/a2025-03-06, From 2023-01-01
2022-12-31$0n/a2024-06-14, From 2022-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Phathom Pharmaceuticals, Inc. (PHAT)2025-12-31$152.51M+222.6%
Cryoport, Inc. (CYRX)2025-12-31$83.05M+19.2%
Lifevantage Corp (LFVN)2026-06-30$141.61M-22.9%
Maravai Lifesciences Holdings, Inc. (MRVI)2025-12-31$33.99M-68.6%
Rhythm Pharmaceuticals, Inc. (RYTM)2025-12-31$170.26M+45.8%
Liquidia Corp (LQDA)2024-12-31$8.12M-44.4%
Heron Therapeutics, Inc. (HRTX)2025-12-31$113.56M+7.5%
Elite Pharmaceuticals Inc (ELTP)2026-03-31$75.02M+87.2%
Amarin Corp PLC (AMRN)2025-12-31$120.87M+48.5%

Compare PHAT, CYRX, LFVN, MRVI side by side · Screen every company in Pharmaceutical Preparations ↗